Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 80425-0207

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 80425-0207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description 2 (Description 2)

Chemical structure diagram of the active ingredient Lisinopril and Hydrochlorothiazide in tablet form, showing molecular bonds and atoms as labeled in the product data.*

FDA Label Image

Description (Description)

Chemical structure of the active ingredient combination Lisinopril and Hydrochlorothiazide, depicting molecular bonds and atomic arrangements characteristic of these compounds.*

FDA Label Image

Label 1 (Lable 1)

Packaging label for Lisinopril and Hydrochlorothiazide 10-12.5 mg tablet by Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions at 20°–25°C (68°–77°F), a comparison to Prinzide, the NDC 80425-0207-03, lot number 90LIS101223, and expiration date 12/9/2023. A barcode and serialization information for Solco Healthcare are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.